Dr. Ken Spielvogel

And that's fine.

Um, you know, some people headache and other, you know, then we're going to go down the line, like you're watching a drug commercial and they're going to list every side effect known to man.

Thyroid tumors was one that they saw in mice.

Uh-huh.

Hasn't been replicated in humans, in human studies thus far.

So, you know, that's kind of where we land in terms of side effect.

The thyroid tumor, uh, the thyroid tumor, uh, is concerning, uh,

but it hasn't been shown in humans.

They've seen it in mice, but hasn't been shown in humans.

And these drugs have been out a while now.

With the Trump administration's new pricing deals dropping costs from well over a thousand bucks a month to roughly 150 to 250 for many people, including some Medicare users, how much does that change access and the overall landscape?

I mean, you make it more affordable than more people are going to have access to it.

That being said, I still think the cost is definitely prohibitive.

When we first started this, I would say if you didn't have an... Not for a drug addict, it's not.

Yeah.

Because if you can spend hundreds of dollars a day getting loaded, you can spend...

a hundred and fifty to two hundred and fifty dollars a month right okay uh to uh make you healthy keep you off drugs right and uh uh i i don't i don't share that yeah yeah i mean it

Accessibility from the standpoint of people being able to see a provider, get a prescription, start the medication, stick themselves, like you said, you're apprehensive about it, stick themselves with a needle once a week.

I still think accessibility is an issue.

Certainly cost reduction's great.